High versus low dose irradiation for tumor immune reprogramming.

Area of Science:

• Oncology
• Immunology
• Radiation Oncology

Background:

• Local ionizing radiation therapy can activate anticancer immune responses, leading to abscopal regression of distant metastases.
• This effect is potentiated in patients receiving systemic immune-checkpoint inhibitors.
• Preclinical data suggest high-dose irradiation releases danger-associated molecular patterns, recruiting immune cells and inducing systemic anti-tumor immunity.

Purpose of the Study:

• To provide the rationale for a clinical research agenda.
• To refine future clinical practice by exploring innovative combinations of radiation and immunotherapy.

Main Methods:

• Review of preclinical evidence on high-dose and low-dose irradiation in cancer treatment.
• Analysis of the mechanisms of radiation-induced immune responses, including danger-associated molecular patterns and immune cell recruitment.
• Synthesis of findings to propose a clinical research agenda.

Main Results:

• High-dose irradiation can induce systemic anti-tumor immunity, protecting against local relapse and mediating distant effects.
• Low-dose irradiation shows potential for tumor immune reprogramming.
• Combining radiation with immunotherapy offers a promising strategy for cancer treatment.

Conclusions:

• Local radiation therapy, particularly in combination with immune-checkpoint inhibitors, can elicit potent systemic anti-cancer immune responses.
• Both high-dose and low-dose irradiation strategies warrant further clinical investigation for their immunomodulatory effects.
• An innovative clinical research agenda is needed to optimize radiation-immunotherapy combinations for improved patient outcomes.